HEOR in the Era of COVID-19

Virtual ISPOR 2020 Preconference Plenary Session

Emerging in late December 2019, an infectious disease caused by a newly discovered coronavirus impacted the world. The World Health Organization declared COVID-19 as a public health emergency of international concern on January 30, 2020 and officially characterized it as a pandemic on March 11, 2020. To mitigate the impact of this new pandemic and the potential social and economic consequences that many countries around the world would face, diverse public health measures were implemented and difficult health care decisions have been taken. At the present time, there are no clearly determined vaccines or treatments for COVID-19, though many clinical trials are in progress, and the future course of this pandemic is uncertain. As the effects of this new virus unfold, there will be more data to be discussed and new questions to be asked. ISPOR 2020 Virtual will be launched on Thursday, May 14, 2020 with an online session on COVID-19 discussing health economics and outcomes research (HEOR) insights and perspectives on the evolving pandemic situation and the implications for short-term and long-term healthcare decisions.

Keynote Address: COVID-19: Accelerating the Evidence to Inform our Response

Mark McClellan, MD, PhD, Director, Duke-Margolis Center for Health Policy, Washington, DC, USA

Panel: COVID-19: A Global Call to Action for Health Economics & Outcomes Researchers


Moderator: Jalpa A. Doshi, PhD, Professor of Medicine, Perelman School of Medicine; Director, Economic Evaluations Unit, Center for Evidence-based Practice; Director, Value-based Insurance Design Initiatives, Center for Health Incentives and Behavioral Economics; Senior Fellow, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA


  • Nuria Oliver, PhD, Commissioner for AI and Covid-19 at the Valencian Government, Chief Data Scientist, Data-Pop Alliance, Chief Scientific Advisor, Vodafone Institute, Co-founder of ELLIS, Alicante, Spain
  • Leo Yee-Sin, MPH, FRCP, FAMS, Executive Director, National Centre for Infectious Diseases, Singapore
  • John H. Powers, MD, FACP, FIDSA, Professor of Clinical Medicine, George Washington University School of Medicine, University of Maryland School of Medicine, Rockville, MD, USA
  • Andrew H Briggs, MSc, DPhil, Professor of Health Economics, Department of Health Services Research & Policy, London School of Hygiene & Tropical Medicine, London, England, UK